For nearly 20 years, the field of diabetic kidney disease (DKD) was essentially stalled without impactful therapeutic advances. However, that landscape has dramatically changed with the recent discovery of kidney and cardiovascular benefits from SGLT2 inhibitors and GLP-1 receptor agonists. In response to these recent advancements, the American Society of Nephrology (ASN) has launched the Diabetic Kidney Disease Collaborative (DKD-C), which is working to raise awareness and to promote dissemination and implementation of optimal treatment to patients with, and at risk for, DKD.
Because a central goal of the DKD-C is to provide education and tools to help nephrologists and
Michael Mauer, MD, will speak on “Diabetic Kidney Disease: Structural–Functional Relationships and the Possibilities of Cure” in the Barry M. Brenner, MD, Endowed Lectureship on Thursday, Nov. 7.
Dr. Mauer is professor of medicine at the University of Minnesota in Minneapolis, where he is a faculty member in both the division of pediatric nephrology and the division of renal diseases and hypertension.
His early clinical research involved the development of hemodialysis methods and kidney transplant strategies and protocols for infants and small children, an interest that continued for years. He began his basic research with studies of
“Person-Centered Dialysis Care: A Patient’s Perspective” is the title of the Celeste Castillo Lee Memorial Lectureship, scheduled for Saturday, Nov. 9.
Derek L. Forfrang
The speaker will be Derek L. Forfrang, a patient advocate who has been a type 1 diabetes patient since age 10. He was diagnosed with CKD in 1990 at age 25, and has been an end stage kidney disease patient since 1998. He has been treated using various modalities including transplantation, peritoneal dialysis, and in-center hemodialysis. He has been a second-time transplant patient since 2013. He received a pancreas transplant in 1998.
The author of the bestseller What Patients Say; What Doctors Hear will give a talk on that subject at a plenary on Sunday, Nov. 10. The book explores how refocusing the conversations between doctors and patients can lead to improved health outcomes.
Danielle Ofri, MD, PhD
Danielle Ofri, MD, PhD, is a practicing internist at New York’s Bellevue Hospital, regular contributor to the New York Times, and best-selling author of several books. She is one of the foremost speakers about the doctor–patient relationship and how to bring humanity back to healthcare.
Hypertension researcher Toshiro Fujita, MD, PhD, will be presented the 2019 Homer W. Smith Award on Sunday, Nov. 10. This award recognizes outstanding contributions to understanding how kidneys function in normal and diseased states.
Toshiro Fujita, MD, PhD
Dr. Fujita will speak on “Salt, Hypertension, and the Kidneys.”
He is a senior fellow at the University of Tokyo’s Research Center for Advanced Science and Technology and chief of the division of clinical epigenetics. He is also an emeritus professor after serving as chair of the department of nephrology and endocrinology at the university’s school of medicine.
Central venous catheter care takes a great deal of dexterity, so much so that some clinicians at Westchester Medical Center’s dialysis clinic say it “takes three hands,” said Renee Garrick, MD, a nephrologist and executive medical director at the center. Yet interruptions during this critical procedure are common—raising the risk of an infection control breach.
Garrick spoke during a webinar hosted by Nephrologists Transforming Dialysis Safety (NTDS), ASN’s partnership with the Centers for Disease Control and Prevention (CDC).
Understanding how such disruptions in critical procedures affect infection control in dialysis settings is one important part of NTDS, which is working
Mitchell Rosner, MD, will receive the Robert G. Narins Award on Saturday, Nov. 9, for his many efforts in education and training the next generation of nephrologists.
Mitchell Rosner, MD
Dr. Rosner is the Henry B. Mulholland Professor of Medicine in the division of nephrology and chairman of the department of medicine at the University of Virginia (UVA).
His clinical practice focuses on the care of patients with all forms of kidney disease, from acute kidney failure to ESKD. His special interest in patients with polycystic kidney disease led Dr. Rosner to found the first regional clinic to specialize in
A winner of the Nobel Prize in Physiology or Medicine will give a state-of-the-art lecture titled “Genes Controlling Sleep and Circadian Rhythms” at the plenary session on Friday, Nov. 8.
Michael Young, PhD
The speaker, Michael Young, PhD, is Richard and Jeanne Fisher Professor and head of the genetics laboratory at The Rockefeller University in New York City. He is also the university’s vice president for academic affairs.
In the late 1970s, Dr. Young began to use the fruit fly, Drosophila, to explore the molecular bases of circadian rhythms. His laboratory used molecular and genetic screens to identify
Perspectives on Innovation and Transformation in Kidney Care” will be the topic of a plenary on Saturday, Nov. 9, that will feature famous inventor Dean Kamen.
Mr. Kamen is an inventor, entrepreneur, and tireless advocate for science and technology. Perhaps best-known for inventing the Segway, he holds more than 440 U.S. and foreign patents, many of them for innovative medical devices that have expanded the frontiers of healthcare worldwide, including the first in-home dialysis device.
While still a college undergraduate, he invented the first wearable infusion pump. In 1976, he founded his first medical device company, AutoSyringe, to